G
Falmouth, MA
Joint Commission
Gosnold Treatment Center
Founded
1972
Program Length
7 Days
Occupancy
31-50 beds
Focus
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Gosnold Treatment Center is a 50-bed detox facility offering medically monitored withdrawal treatment for substance use disorders. Patient stays are typically 4-8 days, and use a variety of medications to treat withdrawal, minimize discomfort, and avert complications. Care is managed by a team of physicians, nurses, counselors, case managers and recovery aides. Programming includes educational sessions each morning, both individual and group counseling, and onsite 12-Step recovery support meetings each evening. Other Gosnold locations offer step-down programs like residential, partial hospitalization (PHP), and intensive outpatient (IOP) treatment, as well as sober living facilities.
Services
Key offerings grouped by category
Type of Care
Substance use treatment
Detoxification
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Hospital inpatient/24-hour hospital inpatient
Hospital inpatient detoxification
Opioid Medications used in Treatment
Buprenorphine used in Treatment
Naltrexone used in Treatment
External Opioid Medications Source
Other contracted prescribing entity
No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Other contracted prescribing entity
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine detoxification
Buprenorphine maintenance
Prescribes buprenorphine
Prescribes naltrexone
Relapse prevention with naltrexone
Accepts clients using MAT but prescribed elsewhere
Lofexidine or Clonidine detoxification
Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®)
Disulfiram
Buprenorphine with naloxone
Buprenorphine without naloxone
Buprenorphine (extended-release, injectable)
Naltrexone (oral)
Naltrexone (extended-release, injectable)
Medications for HIV treatment
Medications for Hepatitis C treatment
Lofexidine
Clonidine
Medication for mental disorders
Nicotine replacement
Non-nicotine smoking/tobacco cessation
Treatment Approaches
Anger management
Brief intervention
Cognitive behavioral therapy
Contingency management/motivational incentives
Motivational interviewing
Matrix Model
Relapse prevention
Substance use disorder counseling
Telemedicine/telehealth therapy
Trauma-related counseling
12-step facilitation
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State Substance use treatment agency
State department of health
The Joint Commission
SAMHSA certification for opioid treatment program (OTP)
Drug Enforcement Agency (DEA)
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs
IHS/Tribal/Urban (ITU) funds
Medicare
Medicaid
Federal military insurance (e.g., TRICARE)
Private health insurance
Cash or self-payment
State-financed health insurance plan other than Medicaid
Special Programs/Groups Offered
Pregnant/postpartum women
Criminal justice (other than DUI/DWI)/Forensic clients
Clients with co-occurring mental and substance use disorders
Clients with HIV or AIDS
Assessment/Pre-treatment
Comprehensive mental health assessment
Comprehensive substance use assessment
Outreach to persons in the community
Complete medical history/physical exam
Screening for tobacco use
Screening for substance use
Screening for mental disorders
Professional interventionist/educational consultant
Testing
Breathalyzer or blood alcohol testing
Drug and alcohol oral fluid testing
Drug or alcohol urine screening
HIV testing
STD testing
TB screening
Metabolic syndrome monitoring
Testing for Hepatitis B (HBV)
Testing for Hepatitis C (HCV)
Transitional Services
Aftercare/continuing care
Discharge Planning
Naloxone and overdose education
Outcome follow-up after discharge
Recovery Support Services
Self-help groups
Housing services
Assistance with obtaining social services
Recovery coach
Mentoring/peer support
Employment counseling or training
Detoxification (medical withdrawal) Services
Alcohol Detoxification
Benzodiazepines Detoxification
Cocaine Detoxification
Methamphetamines detoxification
Opioids detoxification
Medication routinely used during detoxification
Education and Counseling Services
HIV or AIDS education, counseling, or support
Hepatitis education, counseling, or support
Health education services other than HIV/AIDS or hepatitis
Substance use disorder education
Smoking/vaping/tobacco cessation counseling
Individual counseling
Group counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults
Adults
Sex Accepted
Female
Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Acupuncture
Case management service
Mental health services
Social skills development
Transportation assistance
Suicide prevention services
Contact Information
Address
200 Ter Heun Drive, Falmouth, MA, 02540
Phone
(800) 444-1554